Author

Bas L.A.M. Weusten

Endoscopic management of gastrointestinal motility disorders – part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Endoscopic management of gastrointestinal motility disorders – part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Bas L.A.M. Weusten

Endoscopic management of gastrointestinal motility disorders – part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Endoscopic management of gastrointestinal motility disorders – part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Bas L.A.M. Weusten

POEM for non achalasia disorders
POEM for non achalasia disorders

Bas L.A.M. Weusten

Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Bas L.A.M. Weusten  et al.

THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES
THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES

Bas L.A.M. Weusten  et al.

RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS
RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS

Bas L.A.M. Weusten  et al.

MEDIUM-TERM ONCOLOGICAL OUTCOMES FOLLOWING ENDOSCOPIC FULL-THICKNESS RESECTION FOR T1 COLORECTAL CANCER: RESULTS FROM THE DUTCH PROSPECTIVE COLORECTAL EFTR REGISTRY
MEDIUM-TERM ONCOLOGICAL OUTCOMES FOLLOWING ENDOSCOPIC FULL-THICKNESS RESECTION FOR T1 COLORECTAL CANCER: RESULTS FROM THE DUTCH PROSPECTIVE COLORECTAL EFTR REGISTRY

Bas L.A.M. Weusten  et al.

OPTIMAL TIMING OF SIMETHICONE ADMINISTRATION PRIOR TO UPPER ENDOSCOPY: A MULTICENTER SINGLE-BLINDED RANDOMIZED CONTROLLED TRIAL
OPTIMAL TIMING OF SIMETHICONE ADMINISTRATION PRIOR TO UPPER ENDOSCOPY: A MULTICENTER SINGLE-BLINDED RANDOMIZED CONTROLLED TRIAL

Bas L.A.M. Weusten  et al.

ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES
ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES

Bas L.A.M. Weusten  et al.

HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS
HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Bas L.A.M. Weusten  et al.

LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY
LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY

Bas L.A.M. Weusten  et al.

PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX
PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

Bas L.A.M. Weusten  et al.

FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BARRETT ESOPHAGUS. A MULTI- CENTER CROSS SECTIONAL STUDY
FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BARRETT ESOPHAGUS. A MULTI- CENTER CROSS SECTIONAL STUDY

Bas L.A.M. Weusten  et al.

Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative
Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative

Bas L.A.M. Weusten  et al.

COMPUTER AIDED DETECTION SYSTEM FOR REAL-TIME DETECTION OF BARRETT'S NEOPLASIA: A MULTI-CENTER PILOT AND FEASIBILITY STUDY
COMPUTER AIDED DETECTION SYSTEM FOR REAL-TIME DETECTION OF BARRETT'S NEOPLASIA: A MULTI-CENTER PILOT AND FEASIBILITY STUDY

Bas L.A.M. Weusten  et al.

DOMAIN-SPECIFIC PRETRAINING OF DEEP LEARNING SYSTEMS IN GASTROINTESTINAL ENDOSCOPY IMPROVES PERFORMANCE OVER CURRENT STATE-OF-THE-ART PRETRAINING METHODS
DOMAIN-SPECIFIC PRETRAINING OF DEEP LEARNING SYSTEMS IN GASTROINTESTINAL ENDOSCOPY IMPROVES PERFORMANCE OVER CURRENT STATE-OF-THE-ART PRETRAINING METHODS

Bas L.A.M. Weusten  et al.

VIDEO-BASED COMPUTER AIDED DETECTION SYSTEM IMPROVES BARRETT’S NEOPLASIA DETECTION OF GENERAL ENDOSCOPISTS IN A TWO-PHASE BENCHMARKING STUDY
VIDEO-BASED COMPUTER AIDED DETECTION SYSTEM IMPROVES BARRETT’S NEOPLASIA DETECTION OF GENERAL ENDOSCOPISTS IN A TWO-PHASE BENCHMARKING STUDY

Bas L.A.M. Weusten  et al.

European Guideline on Achalasia – UEG and ESNM recommendations
European Guideline on Achalasia – UEG and ESNM recommendations

Bas L.A.M. Weusten  et al.

ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT’S ESOPHAGUS RELATED NEOPLASIA
ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT’S ESOPHAGUS RELATED NEOPLASIA

Bas L.A.M. Weusten  et al.

FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA
FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA

Bas L.A.M. Weusten  et al.

Item 1 - 20 / 23
1
2